Memorial Hermann Health System v. Miguel A. Gomez, III, M.D. and Miguel A. Gomez, M.D., P.A.

CourtTexas Supreme Court
DecidedApril 22, 2022
Docket19-0872
StatusPublished

This text of Memorial Hermann Health System v. Miguel A. Gomez, III, M.D. and Miguel A. Gomez, M.D., P.A. (Memorial Hermann Health System v. Miguel A. Gomez, III, M.D. and Miguel A. Gomez, M.D., P.A.) is published on Counsel Stack Legal Research, covering Texas Supreme Court primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Memorial Hermann Health System v. Miguel A. Gomez, III, M.D. and Miguel A. Gomez, M.D., P.A., (Tex. 2022).

Opinion

Supreme Court of Texas ══════════ No. 19-0872 ══════════

Memorial Hermann Health System, Petitioner,

v.

Miguel A. Gomez, III, M.D. and Miguel A. Gomez, M.D., P.A., Respondents

═══════════════════════════════════════ On Petition for Review from the Court of Appeals for the First District of Texas ═══════════════════════════════════════

Argued October 28, 2021

CHIEF JUSTICE HECHT delivered the opinion of the Court.

Justice Bland did not participate in the decision.

After leaving one hospital for a new rival, a pioneering cardiovascular surgeon sued the former for engaging in a retaliatory “whisper campaign” against him. The surgeon alleged that the hospital used faulty data on his patients’ mortality rates to suppress competition, injure his reputation, and impair his practice. The jury rejected his anticompetition claims but found that the hospital had defamed him and disparaged his professional association. The hospital’s argument that no evidence supports the jury’s defamation and disparagement findings turns on how a reasonable juror would interpret the charge that was given. We hold that the plain text of the charge must be given its commonsense meaning in the context of the case. The court of appeals affirmed the trial court’s judgment for the surgeon. 1 We reverse and render. I A Dr. Miguel A. Gomez, III, is a cardiovascular surgeon who began practicing at one of Memorial Hermann’s Houston campuses, Memorial City, in 1998. He partnered with an established surgeon and pioneered “off-pump” and robotic-assisted heart surgeries. These procedures received media acclaim and were heavily promoted by Memorial Hermann. But around 2008, things began to change—both internally at Memorial City and externally in the Houston hospital market. Internally, Memorial City initiated data-driven programs aimed at examining and improving patient outcomes. As part of this effort, Memorial City hired Byron Auzenne as the heart and vascular service line leader. Auzenne was not directly involved in patient care. Instead, he served as a “facilitator” to the physicians at Memorial City, providing assistance with—in his words—“pretty much anything that they need[ed] to work at the hospital”. Part of Auzenne’s new position involved facilitating data collection and analysis for cardiovascular

1 584 S.W.3d 590 (Tex. App.—Houston [1st Dist.] 2019).

2 surgeons. Patient statistics matter to surgeons and hospitals, who understand what they both do and do not show. A more skilled cardiovascular surgeon may have a higher patient mortality rate than a less skilled surgeon only because of the higher difficulty of surgeries the skilled surgeon takes on. Healthier patients may have better surgical outcomes than those with other health issues. A flawed data sample that fails to take these and other factors into account can produce skewed results that do not accurately reflect a surgeon’s quality of care. Surgeons and hospitals know this. The Society of Thoracic Surgeons (STS) adjusts the raw data that it compiles for seven risk-adjusted procedures so as not to compare surgical apples and oranges. Due to concerns over sample variations, STS does not create any type of surgeon-specific mortality rate. The resulting database is a highly valuable resource for hospitals that raw data cannot serve. A Memorial City physician subcommittee chaired by Gomez recommended that the hospital better utilize STS data and share the data among physicians in the heart and vascular service line. Based on this recommendation and encouragement by the hospital’s administration, Memorial City began to create a process for reviewing the underlying data it sent to STS. Memorial City began with raw, non-risk-adjusted mortality data. Over the summer of 2009, Auzenne met with Memorial City’s CEO Keith Alexander and other leaders in the hospital to discuss some initial findings and concerns. Among other things, their review of the raw data showed that Gomez was a “primary driver” of the hospital’s “unfavorable

3 mortality rate.” Meanwhile, the Houston hospital market was changing. Methodist Hospital announced plans to open a new hospital campus— Methodist West—just miles from Memorial City. The arrival of this new competitor “registered very high on the radar” of Memorial City’s administration, and for good reason. Methodist West’s CEO, Wayne Voss, had previously been Memorial City’s CEO and had relationships with employees and physicians there. Methodist West quickly began to recruit from Memorial City. Voss approached Gomez about operating at Methodist West. The offer interested Gomez, who was beginning to see a negative “culture change” taking place at Memorial City that he believed was adversely affecting patient care. Gomez’s interest in taking at least some of his practice to Methodist West was not a secret. With Methodist West contemplating a future relationship with Gomez, Jennifer Todd of Memorial Hermann made a call to Cyndi Peña at Methodist West. Broadly stated, Todd’s job with Memorial Hermann was to communicate with physicians on behalf of the hospital. Peña had worked with Todd at Memorial Hermann before leaving for Methodist West. Peña’s job at Methodist West included recruiting physicians. Todd called to report concerns about Gomez, telling Peña: “I heard bad quality, high mortality rates, unnecessary surgeries.” According to Peña, this information was “out there already . . . in the ether,” and she had heard similar reports from multiple physicians. Peña reported this information to Methodist West’s CEO, Voss. After reviewing Gomez’s qualifications, Methodist West hired him to provide surgical services and serve as both the “Co-Director of the Cardiovascular Robotics

4 Institute” and “Senior Advisor for Cardiovascular Surgery Service Development at [the] West Houston [campus]”. Back at Memorial City, Gomez’s relationship with the hospital was deteriorating. Word had gotten back to him of the individual surgeon mortality data results. Gomez expressed his concerns to Dr. Rick Ngo, chair of Memorial City’s peer review and surgical performance improvement committee, that the raw data did not accurately reflect a surgeon’s performance. Ngo shared many of Gomez’s misgivings about the data but believed they could be a helpful starting point so long as the hospital used them “the right way with the right methodology.” Ngo expressed his concerns to Auzenne and began a peer review of the cases that made up the dataset. While this review was underway, the non- risk-adjusted data were shared at various surgeon and committee meetings. The data were blinded, and an individual surgeon’s results were shown only to that individual. In early 2010, Ngo and the peer review committee completed the peer review of the cardiovascular surgery program. Ngo found no quality-of-care issues among the cardiovascular surgeons, including Gomez. Ngo specifically communicated this finding to the hospital administration and to Gomez. After looking into the data on a case-by- case basis, Ngo concluded that the non-risk-adjusted data presented a flawed picture of a surgeon’s quality of care. Despite this finding, Memorial City continued to collect and use non-risk-adjusted mortality rates as part of its metrics program. According to Gomez, he did not become aware of the hospital’s continued reliance on this data until a presentation at a cardiovascular

5 subcommittee meeting in November 2011. There, the presentation again showed blinded individual mortality rates of each surgeon—the same information that Gomez believed was faulty. During the meeting, Gomez objected to the data’s use. In response, the presenter told the audience that “only the surgeons that look bad need . . . to be concerned.” After the meeting, Gomez confronted Auzenne about the continued use of non-risk-adjusted data.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Forbes Inc. v. Granada Biosciences, Inc.
124 S.W.3d 167 (Texas Supreme Court, 2003)
Columbia Rio Grande Healthcare, L.P. v. Hawley
284 S.W.3d 851 (Texas Supreme Court, 2009)
Del Lago Partners, Inc. v. Smith
307 S.W.3d 762 (Texas Supreme Court, 2010)
Joseph E. Hancock v. Easwaran P. Variyam
400 S.W.3d 59 (Texas Supreme Court, 2013)
Nip v. Checkpoint Systems, Inc.
154 S.W.3d 767 (Court of Appeals of Texas, 2004)
Osterberg v. Peca
12 S.W.3d 31 (Texas Supreme Court, 2000)
Jackson v. United States Fidelity & Guaranty Co.
689 S.W.2d 408 (Texas Supreme Court, 1985)
City of Brenham v. Honerkamp
950 S.W.2d 760 (Court of Appeals of Texas, 1997)
MBM Financial Corp. v. Woodlands Operating Co.
292 S.W.3d 660 (Texas Supreme Court, 2009)
Saenz v. Fidelity & Guaranty Insurance Underwriters
925 S.W.2d 607 (Texas Supreme Court, 1996)
Bentley v. Bunton
94 S.W.3d 561 (Texas Supreme Court, 2002)
First Federal Savings & Loan Ass'n of Dallas v. Sharp
359 S.W.2d 902 (Texas Supreme Court, 1962)
Hurlbut v. Gulf Atlantic Life Insurance Co.
749 S.W.2d 762 (Texas Supreme Court, 1987)
West v. Cashin
83 S.W.2d 1001 (Court of Appeals of Texas, 1935)
State v. Hale
146 S.W.2d 731 (Texas Supreme Court, 1941)
Broughton v. Humble Oil & Refining Co.
105 S.W.2d 480 (Court of Appeals of Texas, 1937)

Cite This Page — Counsel Stack

Bluebook (online)
Memorial Hermann Health System v. Miguel A. Gomez, III, M.D. and Miguel A. Gomez, M.D., P.A., Counsel Stack Legal Research, https://law.counselstack.com/opinion/memorial-hermann-health-system-v-miguel-a-gomez-iii-md-and-miguel-a-tex-2022.